Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
about
Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virusKaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesKaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with TatKSHV-Mediated Angiogenesis in Tumor ProgressionNext-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) BiologyThe Role of Gammaherpesviruses in Cancer PathogenesisInterplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the HostKaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation.Murine gamma-herpesvirus 68 latency protein M2 binds to Vav signaling proteins and inhibits B-cell receptor-induced cell cycle arrest and apoptosis in WEHI-231 B cells.Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.Overexpression of xCT induces up-regulation of 14-3-3beta in Kaposi's sarcoma.Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic miceThe murine gammaherpesvirus immediate-early Rta synergizes with IRF4, targeting expression of the viral M1 superantigen to plasma cellsA viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression.Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.Antibody evasion by a gammaherpesvirus O-glycan shieldKaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammationLatency-associated nuclear antigen expression and human herpesvirus-8 polymerase chain reaction in the evaluation of Kaposi sarcoma and other vascular tumors in HIV-positive patients.Illumination of murine gammaherpesvirus-68 cycle reveals a sexual transmission route from females to males in laboratory mice.KSHV LANA--the master regulator of KSHV latency.Molecular biology of KSHV lytic reactivation.A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization.Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.Structure and function of latency-associated nuclear antigen.Sequencing of bovine herpesvirus 4 v.test strain reveals important genome features.Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP.KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease developmentRaf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors.Proteomic characterization of bovine herpesvirus 4 extracellular virions.Deletion of Murid Herpesvirus 4 ORF63 Affects the Trafficking of Incoming Capsids toward the NucleusH2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV.Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X ComplexKaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
P2860
Q24543014-5887E630-D92D-4022-A0F4-9D29384E92F8Q24670086-793EB74A-17EF-4D9D-B095-55FBC1B30DE3Q24673761-A52B232F-AAC4-4F53-ABB5-5D546799288EQ24800209-2DFEC8A6-3B75-46F4-B556-A202138262C0Q26742030-9436F12D-063E-4718-BF67-D625021F745BQ26752599-746743AC-A89D-47B5-B1BB-54F4B088644CQ26767186-3BEB0AF7-213A-4B15-875C-413AB498D104Q28080198-F29EC1FD-CD40-4BC6-AF15-3CAC2D3EA744Q30482603-D1D9E2DA-6A2C-4842-BCA3-84E884572069Q33223011-43AA4034-8ECF-4D62-8203-6ACD2E012587Q33282107-27E82208-AAE6-452C-884E-212AFF209F05Q33814766-492D5712-01AA-4158-8772-4B3D2B73D236Q33943771-5569E5DA-EA4D-4A8C-B66E-AFACDCECB3C6Q34015827-52E05A32-AEFB-42BE-90D7-7BD0C22FA5ACQ34055296-C1321E0C-006F-44F1-8B84-C20724B7EBBEQ34071388-00BF8320-5EF5-4D4E-8113-1590205E15E7Q34082672-0D1DD05C-2AA1-4D57-B30D-7DB828F77AF2Q34194120-9939BA54-6AE4-4D1F-95A1-10FBF77B543EQ34513460-DC8B774B-ACBC-47AE-B905-2D3D4D97E11FQ34553088-156ADEBE-3B5D-42B7-952C-4C03F4774144Q34671906-D98BBD3B-2B3E-4754-94B7-CF9324C2F368Q34774797-B87AF0CF-A027-4C3B-ABB3-3FF9EABF45B8Q35014918-1C3443B9-CF24-4F20-9387-7009C3F06480Q35034283-7D8B62A1-9A7A-4A6C-887C-49CE14511605Q35111065-D71E02DA-2138-43B2-BBA9-45D64939BBACQ35124429-867727B4-2775-474F-9FCE-5CB8E6E08E96Q35227739-3496BC14-7399-4823-BA62-75584E334283Q35635192-D0DC78FC-D567-4491-84D0-2C7EFD5D49DAQ35642220-43060C22-45C6-41CD-801A-48CF40B077FAQ35784917-EA5E09BB-74AA-47DD-8DC2-90B1E4EFDFB7Q35911472-3BB24E4B-DCFA-4F34-A7EF-9600AF72F5DDQ36363307-308B013E-58A7-4AF2-919A-1E9CDCF749AAQ36736809-461D53D2-551C-4C66-A3E4-F829A75062F9Q36760020-4AF185F9-CD7A-4D6B-9257-8FEB41C3C1BAQ36870503-55AEFA39-73D2-46A0-BE47-DA0CEDA22458Q37810431-D2F8AE3A-FFA8-41DD-B781-6964C3A5B9D3Q38449592-D6DA9D81-23C2-47FB-8596-BD0C304D678CQ38859450-0C4F2BD5-BD95-4FFE-BE21-ECCECA6A58AFQ38903379-BE012CC7-FDEB-4A07-B6C3-6C1800EAEF96Q39320195-1E01384E-A1E7-4A99-8E34-6D0E4AE5A7C6
P2860
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
@ast
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
@en
type
label
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
@ast
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
@en
prefLabel
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
@ast
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
@en
P1476
Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
@en
P304
P356
10.1016/S0378-1097(03)00261-1
P577
2003-05-01T00:00:00Z